The only way to manage the massive amount patient data being collected today is by using big data in real time, according Dr Keith Dunleavy, president, CEO, chairman of the board for Inovalon, Inc.
The only way to manage the massive amount patient data being collected today is by using big data in real time, according Dr Keith Dunleavy, president, CEO, chairman of the board for Inovalon, Inc.
Not only is patient data is coming in from many disparate locations, but the industry also has access to the individual aspects of a patient, such as compliance with medication and care and follow-up, and their socio-economic data, Dr Dunleavy points out.
Big data becomes the only way really to be able to use this data in order to impact the patient’s experience at the point of care.
“…it has to be done in big data,” he says. “It’s virtually the only way to do it in real time.”
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen